IMFINZI

astrazeneca canada inc🇨🇦 Health Canada

Approval Id: 164182fcb9af3f65
Drug Approval Canada Name: IMFINZI
Product Name: IMFINZI
Status: Marketed
Status Date: 2017-11-20
Original Market Date: 2017-11-20
Din: 02468816
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intravenous
Schedule: Prescription , Schedule D
Ahfs: 10:00.00
Atc Original: L01FF03 DURVALUMAB
Atc Name: l 01 ff 03
Aig Number: 0159570001
Company Name: astrazeneca canada inc
Company Address: 1004 Middlegate Road, Suite 5000, Mississauga, Ontario, Canada, L4Y 1M4

DURVALUMAB

50 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

164182fcb9af3f65

Type

Standard